ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
3
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,297
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Histone deacetylase 6 in cancer
Author(s):
T Li
,
C Zhang
,
S. HASSAN
,
X LIU
,
F Song
,
K. CHEN
,
W Zhang
,
J. Yang
,
M Wu
,
C. LI
,
X Zhu
,
M WU
,
X. ZHU
Publication date:
2018
Journal:
J Hematol Oncol.
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
oa journal (via doaj)
oa repository (via OAI-PMH doi match)
oa repository (via pmcid lookup)
Powered by
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Cancer Metabolism
Author and article information
Journal
PubMed ID::
29298689
DOI::
10.1186/s13045-018-0675-4
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,297
CUDC-101, a multitargeted inhibitor of histone deacetylase, epidermal growth factor receptor, and human epidermal growth factor receptor 2, exerts potent anticancer activity.
Authors:
Cheng-Jung Lai
,
Rudi Bao
,
Xu Tao
…
Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
Authors:
Flávia Verza
,
Umashankar Das
,
Ana Lucia Fachin
…
Novel alkoxyamide-based histone deacetylase inhibitors reverse cisplatin resistance in chemoresistant cancer cells
Authors:
Yodita Asfaha
,
Christian Schrenk
,
Leandro A Alves Avelar
…
See all similar
Cited by
3
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Authors:
Xin Li
,
Yongcheng Song
MicroRNA-548m Suppresses Cell Migration and Invasion by Targeting Aryl Hydrocarbon Receptor in Breast Cancer Cells
Authors:
WM WM Nor
,
Ivy Chung
,
Nur Said
Development of UHPLC-MS/MS Method for Indirubin-3′-Oxime Derivative as a Novel FLT3 Inhibitor and Pharmacokinetic Study in Rats
Authors:
Na Kim
,
Yong-Chul Kim
,
Yoon Gyoon Kim
See all cited by